THRILL Study | Neuroradiologische Klinik Universitätsklinikum Heidelberg | DE - 69120 Heidelberg |
Tel: +49 6221 56 35710 Fax: +49 6221 56 4629

A prospective, open label, blinded endpoint (PROBE), bi-national (Germany and Austria), two-arm, randomized, controlled, post-market study to compare the safety and effectiveness of stent-retrievers as a device class group as compared to best medical care

    THRILL is the first randomized controlled trial solely to study the effect of stent retrievers in patients who are ineligible for IV fibrinolysis